What Is Antimicrobial Resistance?

Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites evolve to resist the effects of medications that once killed them. This makes infections harder — and sometimes impossible — to treat, increasing the risk of disease spread, severe illness, and death.

The World Health Organization has identified AMR as one of the greatest threats to global health, food security, and development. It is a natural biological process, but human actions have dramatically accelerated it.

How Does Resistance Develop?

Every time an antibiotic or antiviral is used, there is a chance that some microbes survive by adapting. These resistant survivors reproduce, passing on their resistance traits. Key drivers include:

  • Overuse of antibiotics in humans — including for viral infections where antibiotics are ineffective
  • Agricultural use — antibiotics are widely used in livestock farming, sometimes as growth promoters
  • Incomplete treatment courses — stopping medication early can leave resistant strains alive
  • Poor infection control — in hospitals and communities, resistant strains spread between patients
  • Lack of new drug development — pharmaceutical companies have little financial incentive to develop new antibiotics

The Scale of the Problem

AMR already causes serious harm globally. Drug-resistant tuberculosis, for instance, requires treatment regimens lasting up to two years using medications with severe side effects — and success rates are far lower than for standard TB. Resistant strains of gonorrhea, pneumonia-causing bacteria, and bloodstream infections are increasingly reported worldwide.

Healthcare systems in both high-income and low-income countries face the burden, though impacts are felt most acutely in regions where infection rates are already high and healthcare infrastructure is limited.

What Is Being Done?

International response to AMR has grown significantly. Key initiatives include:

  1. The Global Action Plan on AMR — a WHO-led framework encouraging countries to develop national action plans
  2. Antimicrobial Stewardship Programs — hospital-based programs that monitor and guide appropriate antibiotic use
  3. Surveillance networks — tracking the emergence and spread of resistant strains globally
  4. Agricultural reforms — several countries have banned or restricted prophylactic antibiotic use in livestock
  5. Research investment — public-private partnerships aimed at incentivizing new antibiotic development

What Can Individuals Do?

While systemic change is needed, individuals also play a role:

  • Only use antibiotics when prescribed by a qualified health professional
  • Always complete the full prescribed course of treatment
  • Never share or use leftover antibiotics
  • Practice good hand hygiene to prevent infections in the first place
  • Ensure vaccinations are up to date — preventing infections reduces the need for antibiotics

A Problem That Requires Global Cooperation

AMR does not respect borders. A resistant pathogen emerging in one country can spread globally within days through travel and trade. Addressing it requires coordinated international policy, sustained investment in research, and a shift in how healthcare systems and agriculture approach the use of antimicrobials. The window to act before resistance becomes unmanageable is narrowing — making public awareness and political will more critical than ever.